Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00023610.xml
Drug Res (Stuttg) 2016; 66(11): 580-586
DOI: 10.1055/s-0042-112811
DOI: 10.1055/s-0042-112811
Review
An Update on Biomedical Application of Nanotechnology for Alzheimer’s Disease Diagnosis and Therapy
Further Information
Publication History
received 07 July 2016
accepted 12 July 2016
Publication Date:
04 October 2016 (online)


Abstract
Approximately 35 million people worldwide suffer from Alzheimer’s disease (AD). The cellular uptake and specific transport of drugs and imaging agents to brain are common issues in the diagnosis and therapy of AD. New advances in nanotechnology have supplied favorable solutions to this issue. Various nanocarriers such as polymeric nanoparticles, liposomes, micelles, dendrimers and nanogels have been studied for the delivery of drugs and imaging agents to brain. This review presents a succinct discussion of the applications of nanotechnology for Alzheimer’s disease diagnosis and therapy.